Secondary Acute Myeloid Leukemia Clinical Trials in Düsseldorf, North Rhine-Westphalia

Venetoclax in Addition to Sequential Conditioning With Fludarabine / Amsacrine / Ara-C (FLAMSA) + Treosulfan for Allogeneic Blood Stem Cell Transplantation in Patients With MDS, CMML or sAML